Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor
Health‐related quality of life · DCM (non‐ischaemic)
1 finding from 1 review
- no estimate extracted1 study · 22 participantsLow
Findings
What do systematic reviews say?
6 questions · 6 findings · 1 reviews · Heart
No studies found 0 · 0%GRADE not reported 2 · 33.3%Very low 2 · 33.3%Low 2 · 33.3%Moderate 0 · 0%High 0 · 0%
Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor
Performance status – functional class (NYHA) · DCM (non‐ischaemic)
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor
Functional capacityAssessed: 6MWT · DCM (non‐ischaemic)
1 finding from 1 review
- no estimate extracted2 studies · 155 participantsLow
Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor
MACE · DCM (non‐ischaemic)
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor
All‐cause mortality · DCM (non‐ischaemic)
It is very uncertain whether stem cell therapy (any type) changes all‐cause mortality compared with peripheral therapy with granulocyte colony‐stimulating factor (very low certainty).
1 finding from 1 review
- RR 0.46 [0.16, 1.31]3 studies · 195 participantsVery low
Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor
Procedural complications · DCM (non‐ischaemic)
1 finding from 1 review
- no estimate extracted1 study · 60 participantsVery low